Open house drug discount contracts for the active ingredient Pancreatin, …

This tender is an 'Open House' procedure initiated by AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse (AOK Rhineland-Palatinate/Saarland - The Health Insurance Fund). The objective is to establish drug discount contracts for medications containing the active ingredient Pancreatin. This type of procedure allows multiple suppliers to enter into agreements over a defined period. The contracts will focus on achieving cost reductions for the health insurance fund through negotiated discounts on Pancreatin-based pharmaceuticals. Bidders will need to meet specific quality and supply requirements. Further details on the active ingredient, required dosage forms, packaging, and contract terms are available from the issuing authority. The service.bund.de portal is used for announcement only; all inquiries and submissions must be directed to AOK Rheinland-Pfalz/Saarland.

This is a supplies contract in the health and medical services and finance and banking sectors, with a focus on Pharmaceuticals, Health Financing and Insurance. Located in Germany, Europe, this opportunity is open to firms and consortiums. Proposals must be submitted before February 29, 2028.

Published through service.bund.de (Germany), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. Interested parties should review the full documentation on the original source before submitting their proposal.